Cargando…

Impact of antiretroviral treatment on height evolution of HIV infected children

BACKGROUND: Antiretroviral treatment (ART) has been shown to have a beneficial effect on the weight evolution but its effect on height remains unclear. We described patterns of height evolution and identified predictors of catch-up growth in HIV-infected children on ART. METHODS: To describe the hei...

Descripción completa

Detalles Bibliográficos
Autores principales: Traisathit, Patrinee, Urien, Saïk, Le Coeur, Sophie, Srirojana, Sakulrat, Akarathum, Noppadon, Kanjanavanit, Suparat, Ngampiyaskul, Chaiwat, Krikajornkitti, Sawitree, Ngo-Giang-Huong, Nicole, Lallemant, Marc, Jourdain, Gonzague
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697969/
https://www.ncbi.nlm.nih.gov/pubmed/31421667
http://dx.doi.org/10.1186/s12887-019-1663-8
_version_ 1783444463893348352
author Traisathit, Patrinee
Urien, Saïk
Le Coeur, Sophie
Srirojana, Sakulrat
Akarathum, Noppadon
Kanjanavanit, Suparat
Ngampiyaskul, Chaiwat
Krikajornkitti, Sawitree
Ngo-Giang-Huong, Nicole
Lallemant, Marc
Jourdain, Gonzague
author_facet Traisathit, Patrinee
Urien, Saïk
Le Coeur, Sophie
Srirojana, Sakulrat
Akarathum, Noppadon
Kanjanavanit, Suparat
Ngampiyaskul, Chaiwat
Krikajornkitti, Sawitree
Ngo-Giang-Huong, Nicole
Lallemant, Marc
Jourdain, Gonzague
author_sort Traisathit, Patrinee
collection PubMed
description BACKGROUND: Antiretroviral treatment (ART) has been shown to have a beneficial effect on the weight evolution but its effect on height remains unclear. We described patterns of height evolution and identified predictors of catch-up growth in HIV-infected children on ART. METHODS: To describe the height evolution from birth to adulthood, we developed a nonlinear mixed effect model using data from perinatally HIV-infected children who initiated ART from 1999 to 2013 in a prospective cohort study in Thailand. The main covariates of interest were: sex, ART regimen (dual nucleoside reverse-transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor (NNRTI)-, or protease inhibitor (PI)-based), baseline CD4 percentage, HIV-RNA load and CDC HIV Classification stage and occurrence of AIDS-defining events. RESULTS: A total 477 children (43% boys) contributed 18,596 height measurements over a median duration of 6.3 years on ART (interquartile range, 3.0 to 8.3). At ART initiation, median age was 6.2 years (1.8 to 9.6), 16% of children were underweight (weight-for-age z-score < − 2), 49% presented stunting (height-for-age z-score < − 2), and 7% wasting (weight-for-height z-score < − 2). The most frequent regimen at ART initiation was NNRTI-based (79%). A model with 4 components, birth length and 3 exponential functions of age accounting for the 3 growth phases was developed and show that the height-growth velocity was inversely associated with the age at ART initiation, the adult height was significantly lower in those who had experienced at least one AIDS-defining event while, as expected, the model found that adult height in females was lower than in males. Age at ART initiation, type of ART regimen, CDC stage, CD4 percentages, and HIV-RNA load were not associated with the final height. CONCLUSIONS: The younger the children at ART initiation, the greater the effect on height-growth velocity, supporting the World Health Organization’s recommendation to start ART as early as possible. However, final adult height was not linked to the age at ART initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12887-019-1663-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6697969
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66979692019-08-19 Impact of antiretroviral treatment on height evolution of HIV infected children Traisathit, Patrinee Urien, Saïk Le Coeur, Sophie Srirojana, Sakulrat Akarathum, Noppadon Kanjanavanit, Suparat Ngampiyaskul, Chaiwat Krikajornkitti, Sawitree Ngo-Giang-Huong, Nicole Lallemant, Marc Jourdain, Gonzague BMC Pediatr Research Article BACKGROUND: Antiretroviral treatment (ART) has been shown to have a beneficial effect on the weight evolution but its effect on height remains unclear. We described patterns of height evolution and identified predictors of catch-up growth in HIV-infected children on ART. METHODS: To describe the height evolution from birth to adulthood, we developed a nonlinear mixed effect model using data from perinatally HIV-infected children who initiated ART from 1999 to 2013 in a prospective cohort study in Thailand. The main covariates of interest were: sex, ART regimen (dual nucleoside reverse-transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor (NNRTI)-, or protease inhibitor (PI)-based), baseline CD4 percentage, HIV-RNA load and CDC HIV Classification stage and occurrence of AIDS-defining events. RESULTS: A total 477 children (43% boys) contributed 18,596 height measurements over a median duration of 6.3 years on ART (interquartile range, 3.0 to 8.3). At ART initiation, median age was 6.2 years (1.8 to 9.6), 16% of children were underweight (weight-for-age z-score < − 2), 49% presented stunting (height-for-age z-score < − 2), and 7% wasting (weight-for-height z-score < − 2). The most frequent regimen at ART initiation was NNRTI-based (79%). A model with 4 components, birth length and 3 exponential functions of age accounting for the 3 growth phases was developed and show that the height-growth velocity was inversely associated with the age at ART initiation, the adult height was significantly lower in those who had experienced at least one AIDS-defining event while, as expected, the model found that adult height in females was lower than in males. Age at ART initiation, type of ART regimen, CDC stage, CD4 percentages, and HIV-RNA load were not associated with the final height. CONCLUSIONS: The younger the children at ART initiation, the greater the effect on height-growth velocity, supporting the World Health Organization’s recommendation to start ART as early as possible. However, final adult height was not linked to the age at ART initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12887-019-1663-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-17 /pmc/articles/PMC6697969/ /pubmed/31421667 http://dx.doi.org/10.1186/s12887-019-1663-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Traisathit, Patrinee
Urien, Saïk
Le Coeur, Sophie
Srirojana, Sakulrat
Akarathum, Noppadon
Kanjanavanit, Suparat
Ngampiyaskul, Chaiwat
Krikajornkitti, Sawitree
Ngo-Giang-Huong, Nicole
Lallemant, Marc
Jourdain, Gonzague
Impact of antiretroviral treatment on height evolution of HIV infected children
title Impact of antiretroviral treatment on height evolution of HIV infected children
title_full Impact of antiretroviral treatment on height evolution of HIV infected children
title_fullStr Impact of antiretroviral treatment on height evolution of HIV infected children
title_full_unstemmed Impact of antiretroviral treatment on height evolution of HIV infected children
title_short Impact of antiretroviral treatment on height evolution of HIV infected children
title_sort impact of antiretroviral treatment on height evolution of hiv infected children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697969/
https://www.ncbi.nlm.nih.gov/pubmed/31421667
http://dx.doi.org/10.1186/s12887-019-1663-8
work_keys_str_mv AT traisathitpatrinee impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT uriensaik impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT lecoeursophie impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT srirojanasakulrat impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT akarathumnoppadon impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT kanjanavanitsuparat impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT ngampiyaskulchaiwat impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT krikajornkittisawitree impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT ngogianghuongnicole impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT lallemantmarc impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren
AT jourdaingonzague impactofantiretroviraltreatmentonheightevolutionofhivinfectedchildren